Galenica Sante AG Cash Flow Conversion Efficiency
Galenica Sante AG cash flow conversion efficiency. Based on the latest financial reports, Galenica Sante AG (GALE) has a cash flow conversion efficiency ratio of 0.129x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CHF190.83 Million ≈ $241.26 Million USD) by net assets (CHF1.49 Billion ≈ $1.88 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Galenica Sante AG (2014–2025)
Cash flow conversion efficiency of Galenica Sante AG from 2014 to 2025. This chart illustrates how Galenica Sante AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Galenica Sante AG share price for real-time trading data and today's change.
Galenica Sante AG Cash Flow Conversion Ratio Explained
Galenica Sante AG cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Galenica Sante AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Galenica Sante AG ranked by their cash flow conversion efficiency. Also see how much is Galenica Sante AG worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Persimmon Plc
F:OHP
|
-0.038x |
|
LG Uplus
KO:032640
|
0.108x |
|
Adecco Group AG Class N
SW:ADEN
|
0.006x |
|
Northland Power Inc.
TO:NPI
|
0.037x |
|
Suzhou TA&A Ultra Clean Technology Co Ltd
SHE:300390
|
-0.037x |
|
PBF Energy Inc
NYSE:PBF
|
0.005x |
|
Dun & Bradstreet Holdings Inc.
NYSE:DNB
|
0.023x |
|
Turkcell Iletisim Hizmetleri A.S
F:TUL1
|
0.093x |
Annual Cash Flow Conversion Efficiency for Galenica Sante AG (2014–2025)
The table below shows the annual cash flow conversion efficiency of Galenica Sante AG from 2014 to 2025. Review GALE cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CHF1.49 Billion ≈ $1.88 Billion |
CHF299.76 Million ≈ $378.98 Million |
0.202x | +18.34% |
| 2024-12-31 | CHF1.55 Billion ≈ $1.96 Billion |
CHF264.70 Million ≈ $334.66 Million |
0.171x | +11.48% |
| 2023-12-31 | CHF1.48 Billion ≈ $1.87 Billion |
CHF225.71 Million ≈ $285.36 Million |
0.153x | -19.29% |
| 2022-12-31 | CHF1.25 Billion ≈ $1.58 Billion |
CHF236.87 Million ≈ $299.47 Million |
0.190x | -29.79% |
| 2021-12-31 | CHF1.23 Billion ≈ $1.56 Billion |
CHF333.10 Million ≈ $421.12 Million |
0.270x | +26.76% |
| 2020-12-31 | CHF1.05 Billion ≈ $1.33 Billion |
CHF224.36 Million ≈ $283.65 Million |
0.213x | -14.99% |
| 2019-12-31 | CHF999.54 Million ≈ $1.26 Billion |
CHF250.44 Million ≈ $316.62 Million |
0.251x | +34.78% |
| 2018-12-31 | CHF933.60 Million ≈ $1.18 Billion |
CHF173.55 Million ≈ $219.41 Million |
0.186x | +10.91% |
| 2017-12-31 | CHF861.51 Million ≈ $1.09 Billion |
CHF144.40 Million ≈ $182.56 Million |
0.168x | -64.28% |
| 2016-12-31 | CHF334.20 Million ≈ $422.53 Million |
CHF156.82 Million ≈ $198.26 Million |
0.469x | -8.17% |
| 2015-12-31 | CHF259.19 Million ≈ $327.69 Million |
CHF132.44 Million ≈ $167.43 Million |
0.511x | +45.94% |
| 2014-12-31 | CHF240.26 Million ≈ $303.76 Million |
CHF84.12 Million ≈ $106.35 Million |
0.350x | -- |
About Galenica Sante AG
Galenica AG provides healthcare services in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates and manages pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands, as well as covers specialty pharmacy mediservice. This segment also offers medication for treatment of patients … Read more